Merav Kaye - Hadasit Bio Director
| HDST Stock | 53.10 0.00 0.00% |
Director
Ms. Merav Kaye was appointed Director at HBL Hadasit Bio Holdings Ltd., effective March 26, 2014 since 2014.
| Age | 44 |
| Tenure | 10 years |
| Phone | 972 2 677 8757 |
| Web | https://www.hbl.co.il |
Hadasit Bio Management Efficiency
The company has return on total asset (ROA) of (0.0296) % which means that it has lost $0.0296 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4387) %, meaning that it generated substantial loss on money invested by shareholders. Hadasit Bio's management efficiency ratios could be used to measure how well Hadasit Bio manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Gwen Melincoff | Kamada | 64 | |
| Alex Kornhauser | Tower Semiconductor | 71 | |
| Shmuel Rubinstein | Kamada | 78 | |
| Robert Fishel | Opko Health | 56 | |
| Richard Krasno | Opko Health | 76 | |
| Leon Recanati | Kamada | 69 | |
| Thomas Beier | Opko Health | 69 | |
| John Paganelli | Opko Health | 83 | |
| Alice Yu | Opko Health | 74 | |
| Ziv Kop | Kamada | 43 | |
| Sagi Kabla | Tower Semiconductor | 38 | |
| Dana Gross | Tower Semiconductor | 51 | |
| Reuven Behar | Kamada | 60 | |
| Yoav Doppelt | Tower Semiconductor | 46 | |
| Abraham Havron | Kamada | 70 | |
| Richard Pfenniger | Opko Health | 62 | |
| Richard Lerner | Opko Health | 79 | |
| Itzhak Krinsky | Kamada | 65 | |
| Avraham Guzman | Tower Semiconductor | 79 | |
| Estery GilozRan | Kamada | 44 | |
| Dmitry Kolosov | Opko Health | 36 | |
Management Performance
| Return On Equity | -0.44 | |||
| Return On Asset | -0.0296 |
Hadasit Bio Leadership Team
Elected by the shareholders, the Hadasit Bio's board of directors comprises two types of representatives: Hadasit Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hadasit. The board's role is to monitor Hadasit Bio's management team and ensure that shareholders' interests are well served. Hadasit Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hadasit Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yaakov Naparstek, Director | ||
| Yigal Erlich, Director | ||
| Oren Levy, Sr Director | ||
| Rob Fink, IR Contact Officer | ||
| Merav Kaye, Director | ||
| Michal Sapir, External Director | ||
| Baruch Halpert, Chairman of the Board | ||
| Alejandro Igelman, VP Fin | ||
| Doron Cohen, Internal Auditor | ||
| Michel Habib, CEO | ||
| Asaf Reisfeld, Director | ||
| Yoram Azulay, Vice President - Finance | ||
| Doron Nevo, External Director | ||
| Ophir Shahaf, CEO | ||
| Yaron Kulas, External Director | ||
| Ehud Kokia, Director | ||
| Einat Zisman, Director | ||
| Moise Habib, CEO | ||
| Tamar Raz, Director | ||
| Elka Nir, External Director | ||
| Erez Meltzer, Director | ||
| Yoram Azulai, VP CFO |
Hadasit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hadasit Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.44 | |||
| Return On Asset | -0.0296 | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | (3.4 M) | |||
| Shares Outstanding | 11.09 M | |||
| Shares Owned By Insiders | 74.99 % | |||
| Price To Book | 0.52 X | |||
| Price To Sales | 0.90 X | |||
| Gross Profit | 35.09 M | |||
| EBITDA | 28.67 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hadasit Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Hadasit Stock analysis
When running Hadasit Bio's price analysis, check to measure Hadasit Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hadasit Bio is operating at the current time. Most of Hadasit Bio's value examination focuses on studying past and present price action to predict the probability of Hadasit Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hadasit Bio's price. Additionally, you may evaluate how the addition of Hadasit Bio to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |